Cross sectional study

Last updated: November 01, 2022

Cross sectional study

Step 2

Step 2

Pharyngeal arches, pouches, and clefts
Adrenocorticotropic hormone
Growth hormone and somatostatin
Cortisol
Estrogen and progesterone
Testosterone
Phosphate, calcium and magnesium homeostasis
Vitamin D
Parathyroid hormone
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Diabetes mellitus: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Diabetes insipidus and SIADH: Pathology review
Multiple endocrine neoplasia: Pathology review
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Adrenal hormone synthesis inhibitors
Mineralocorticoids and mineralocorticoid antagonists
Mean, median, and mode
Type I and type II errors
Sensitivity and specificity
Positive and negative predictive value
Odds ratio
Relative and absolute risk
Cross sectional study
Cohort study
Case-control study
Randomized control trial
Confounding
Selection bias
Gastrointestinal hormones
Congenital gastrointestinal disorders: Pathology review
Esophageal disorders: Pathology review
Inflammatory bowel disease: Pathology review
Malabsorption syndromes: Pathology review
Gastrointestinal bleeding: Pathology review
Colorectal polyps and cancer: Pathology review
Gallbladder disorders: Pathology review
Viral hepatitis: Pathology review
Cirrhosis: Pathology review
Laxatives and cathartics
Acid reducing medications
Antidiarrheals
Blood groups and transfusions
Platelet plug formation (primary hemostasis)
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
Coagulation (secondary hemostasis)
Non-hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Microcytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Platelet disorders: Pathology review
Coagulation disorders: Pathology review
Macrocytic anemia: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Leukemias: Pathology review
Myeloproliferative disorders: Pathology review
Plasma cell disorders: Pathology review
Anticoagulants: Heparin
Anticoagulants: Direct factor inhibitors
Anticoagulants: Warfarin
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Ribonucleotide reductase inhibitors
Platinum containing medications
Microtubule inhibitors
Monoclonal antibodies
Topoisomerase inhibitors
Anti-tumor antibiotics
DNA alkylating medications
Antimetabolites for cancer treatment
Lung volumes and capacities
Anatomic and physiologic dead space
Combined pressure-volume curves for the lung and chest wall
Diffusion-limited and perfusion-limited gas exchange
Alveolar gas equation
Oxygen-hemoglobin dissociation curve
Oxygen binding capacity and oxygen content
Carbon dioxide transport in blood
Pulmonary changes at high altitude and altitude sickness
Pulmonary changes during exercise
Respiratory distress syndrome: Pathology review
Cystic fibrosis: Pathology review
Tuberculosis: Pathology review
Pneumonia: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Lung cancer and mesothelioma: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Antihistamines for allergies
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Development of the reproductive system
Menstrual cycle
Menopause
Pregnancy
Oxytocin and prolactin
Breastfeeding
Puberty and Tanner staging
Disorders of sex chromosomes: Pathology review
Prostate disorders and cancer: Pathology review
Testicular tumors: Pathology review
Uterine disorders: Pathology review
Ovarian cysts and tumors: Pathology review
Cervical cancer: Pathology review
Vaginal and vulvar disorders: Pathology review
Breast cancer: Pathology review
Benign breast conditions: Pathology review
Complications during pregnancy: Pathology review
Congenital TORCH infections: Pathology review
Androgens and antiandrogens
Adrenergic antagonists: Alpha blockers
PDE5 inhibitors
Estrogens and antiestrogens
Uterine stimulants and relaxants
Progestins and antiprogestins
Aromatase inhibitors

Questions

USMLE® Step 1 style questions USMLE

0 of 1 complete

USMLE® Step 2 style questions USMLE

0 of 1 complete

A researcher is attempting to understand the prevalence of hypertension in a small island population. The researcher enrolls approximately 15,000 patients and contemplates which study design is best suited, to determine what (if any) exposures result in a high or low prevalence of hypertension at a single point in time. Which of the following types of studies is best suited to answer this researcher’s question?  

Transcript

Watch video only

A cross- sectional study is a study design where an exposure and an outcome are measured at the same time.

For example, let’s say you want to figure out if people who are obese – which means having a body mass index or BMI of 30 or higher - have higher serum cholesterol levels compared to people who are not obese – having a body mass index below 30.

To do this, you might look at the medical records of 100 people to see who has high cholesterol levels and who has low cholesterol levels and compare that to how many people in each group are obese or not obese.

You can think about a cross-sectional study like a snapshot of the population at a certain point in time.

Since you can only collect the information you see in that one moment, you don’t know what happens before or after the snapshot was taken.

So, we can only collect information on prevalence – the proportion of exposures or outcomes that already exist at a certain time – and not incidence – the proportion of new exposures or outcomes that occur in a certain time period.

In terms of prevalence, there’s an outcome prevalence and an exposure prevalence.

The outcome prevalence is the proportion of people who have an outcome in the exposed group and the non-exposed group.

In a cross-sectional study this can be organized in a 2 by 2 table, with the exposure – obesity or no obesity – on the side and the outcome – high or low cholesterol levels – on the top, and each box is labeled a, b, c, or d.

Cell a includes individuals who have high cholesterol and who are obese; cell b includes individuals who have low cholesterol and who are obese; cell c includes individuals who have high cholesterol and who are not obese; and cell d includes individuals who have low cholesterol and who are not obese.

We can calculate an outcome prevalence to figure out if high cholesterol – the outcome – is more prevalent for people who are obese or not obese – the exposure.

Let’s say that there are 50 people in cell a, 15 in cell b, 5 in cell c, and 30 in cell d.

To find the outcome prevalence, we first calculate the proportion of people who have high cholesterol in the group that is obese – so “a” divided by “a plus b”, or 50 divided by 65, which rounds to 0.77.

Then we compare it with the proportion of people who have high cholesterol in the group who are not obese – so “c” divided by “c plus d”, or 5 divided by 35, which rounds to 0.14.

And, 0.77 divided by 0.14 equals 5.5, which means that the people who are obese have about 5.5 times the prevalence of high cholesterol compared to people who are not obese.

We can similarly calculate the exposure prevalence, which is a comparison of the proportion of people who have an exposure in the outcome group and the no outcome groups.

For example, we might calculate the exposure prevalence to figure out if obesity – the exposure – is more prevalent for people who have high cholesterol or low cholesterol – the outcome.

To find the exposure prevalence, we first calculate the proportion of people who are obese in the group that has high cholesterol– so “a” divided by “a plus c”, or 50 divided by 55, which is 0.91.

We then compare it to the proportion of people who are obese in the group that has low cholesterol – so “b” divided by “b plus d”, or 15 divided by 45, which is 0.33.

Key Takeaways

A cross-sectional study is a type of observational study that assesses the relationship between exposures and outcomes at a single point in time. It can be used to study factors associated with an outcome. In a cross-sectional study, data are collected from a group of participants who have been followed for a certain length of time. Data are then analyzed to see if there is an association between the different exposures and the outcome measure. Cross-sectional are usually quick and cheap studies that help to sample large groups of people.